The first biotech incubator

Merck Serono, a division of the German giant Merck, is investing at least 10 million euros in a project to grow Israeli biotech companies. Israeli start-ups can use Merck’s R&D InterLab facilities in Yavneh for research in order to bring new drugs to market.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *